Wednesday, March 29, 2006


Hepatitis C Facts - Vertex Pharma's Hep C Drug Could See $1.7B Sales


Vertex Pharma's Hep C Drug Could See $1.7B Sales
Forbes - Mar 14, 2006ThinkEquity Partners lowered the price target on Vertex Pharmaceuticals to $40 from $48 and said more data will be needed in order to determine the potential ...

Patients e-records facing legal hurdles
Kansas City Star, MO - Feb 28, 2006... The organization recently moved to 10603 Blue Ridge Blvd. There s no cure, and there s no vaccine for hep C, she said. ...

Human Genome Sciences Seen Partnering Hep C Drug In 2006
Forbes - Mar 16, 2006Piper Jaffray maintained an "outperform" rating on Human Genome Sciences and advised investors to buy on recent weakness in the stock. ...

Needle exchange made possible
Merritt Herald, Canada - 11 hours ago... "For me this is a ministry of humanity and a small way that we can be involved in the prevention of the spread of Hep C and HIV.". ...

Novartis Seen 'Saving Face' With Idenix Hep C Deal
Forbes - 13 hours ago... a research report Wednesday. "We think NM283 will make it to market and become a competitive hep C player.". Idenix shares fell 28 ...

Monday, March 27, 2006


Hepatitis C Facts - Fatty Liver


Fatty Liver
Title: Fatty LiverCategory: Diseases and ConditionsCreated: 12/31/1997Last Editorial Review: 8/29/2005

Vaccination Tames Hepatitis A Infection
Title: Vaccination Tames Hepatitis A InfectionCategory: Health NewsCreated: 7/13/2005 1:58:00 AMLast Editorial Review: 7/13/2005 1:58:14 AM

Health Notes: Healthways expands contract with Blue Cross of ...
Blink: Hepatitis C Added by mfeed Nashville Tennessean - Healthways Inc. has entered into a new five-year contract with Blue Cross Blue Shield of Massachusetts to continue offering disease-management services to the health plan's chronically ill members. Under the new contract, which begins April 1 ...... Read more... blink it

Liver Cancer, Hepatitis C Connection Gets Clearer
Title: Liver Cancer, Hepatitis C Connection Gets ClearerCategory: Health NewsCreated: 12/8/2005 1:59:00 AMLast Editorial Review: 12/8/2005 1:58:50 AM